+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Corium International Inc (CORI) - Product Pipeline Analysis, 2018 Update

  • PDF Icon

    Company Profile

  • 37 Pages
  • August 2018
  • Region: Global
  • GlobalData
  • ID: 4612529
Summary

Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products include Corplex Memantine and Corplex Donepezil for the treatment of Alzheimer’s disease. Corium also develops MicroCor PTH for the treatment of osteoporosis using another technology platform called MicroCor system. The company provides proprietary development programs, contract research and development services. It partners with pharmaceutical and consumer products companies. The company operates through its research and development facility in Grand Rapids, the US. Corium is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

  • The report analyzes all pipeline products in development for the company Corium International Inc

  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

  • The report provides detailed description of products in development, technical specification and functions

  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

  • To formulate effective Research & Development strategies

  • Develop market-entry and market expansion strategies

  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Corium International Inc Company Overview
Corium International Inc Company Snapshot
Corium International Inc Pipeline Products and Ongoing Clinical Trials Overview
Corium International Inc – Pipeline Analysis Overview
Corium International Inc - Key Facts
Corium International Inc - Major Products and Services
Corium International Inc Pipeline Products by Development Stage
Corium International Inc Ongoing Clinical Trials by Trial Status
Corium International Inc Pipeline Products Overview
Corplex Donepezil Transdermal System
Corplex Donepezil Transdermal System Product Overview
Corplex Donepezil Transdermal System Clinical Trial
Corplex Memantine Transdermal System
Corplex Memantine Transdermal System Product Overview
Corplex Ropinirole Transdermal System
Corplex Ropinirole Transdermal System Product Overview
Island Dressing
Island Dressing Product Overview
MicroCor Transdermal System
MicroCor Transdermal System Product Overview
MicroCor Zolmitriptan System
MicroCor Zolmitriptan System Product Overview
MicroJet
MicroJet Product Overview
Rapidly Dissolving Film
Rapidly Dissolving Film Product Overview
Solid State Film
Solid State Film Product Overview
Corium International Inc - Key Competitors
Corium International Inc - Key Employees
Corium International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Corium International Inc, Recent Developments
Jul 11, 2018: Corium Announces Issuance of Additional U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer''s Disease
Jun 13, 2018: Corium Announces Issuance of Key U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer’s Disease
May 14, 2018: Corium Announces Second Quarter Fiscal 2018 Financial Results
Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
Nov 16, 2017: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights
Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017
Jul 18, 2017: Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
Jul 06, 2017: Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017
May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights
May 11, 2017: Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study
Appendix
Methodology
About
Contact
Disclaimer

List of Tables
Corium International Inc Pipeline Products and Ongoing Clinical Trials Overview
Corium International Inc Pipeline Products by Equipment Type
Corium International Inc Pipeline Products by Indication
Corium International Inc Ongoing Clinical Trials by Trial Status
Corium International Inc, Key Facts
Corium International Inc, Major Products and Services
Corium International Inc Number of Pipeline Products by Development Stage
Corium International Inc Pipeline Products Summary by Development Stage
Corium International Inc Ongoing Clinical Trials by Trial Status
Corium International Inc Ongoing Clinical Trials Summary
Corplex Donepezil Transdermal System - Product Status
Corplex Donepezil Transdermal System - Product Description
Corplex Donepezil Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease
Corplex Memantine Transdermal System - Product Status
Corplex Memantine Transdermal System - Product Description
Corplex Ropinirole Transdermal System - Product Status
Corplex Ropinirole Transdermal System - Product Description
Island Dressing - Product Status
Island Dressing - Product Description
MicroCor Transdermal System - Product Status
MicroCor Transdermal System - Product Description
MicroCor Zolmitriptan System - Product Status
MicroCor Zolmitriptan System - Product Description
MicroJet - Product Status
MicroJet - Product Description
Rapidly Dissolving Film - Product Status
Rapidly Dissolving Film - Product Description
Solid State Film - Product Status
Solid State Film - Product Description
Corium International Inc, Key Employees
Corium International Inc, Other Locations
Glossary

List of Figures
Corium International Inc Pipeline Products by Equipment Type
Corium International Inc Pipeline Products by Development Stage
Corium International Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agile Therapeutics Inc
  • ActiveCare Inc
  • BG Medicine Inc